CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
MR-imaging features of patients with hepatocellular carcinoma following sorafenib monotherapy: incidence, time of occurrence and clinical significance
DOI 10.1055/s-0028-1089652
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Bitzer, UM Lauer, C Schraml, U Koppenhöfer, CD Clausen, M Gregor, M Horger
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
The aim of this study was to assess MRI signal changes in hepatocellular carcinoma (HCC) patients after initiation of a monotherapy with the new oral multikinase inhibitor sorafenib. Twelve patients (age range, 58–72 years; mean, 65.4 years) with inoperable HCC and no prior systemic treatment received oral sorafenib 800mg daily (2×400mg bid) and underwent MRI at baseline and then every 4 to 6 weeks. Survey time rang…
Zitieren
Zitierempfehlung
M Bitzer, UM Lauer, C Schraml, U Koppenhöfer, CD Clausen, M Gregor, M Horger (2008) MR-imaging features of patients with hepatocellular carcinoma following sorafenib monotherapy: incidence, time of occurrence and clinical significance. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0028-1089652
Mit CareLit weiterarbeiten